Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Mirkin, Chad
Professor
Bio
Prof. Mirkin has pioneered the use of nanoparticle-biomolecule conjugates as synthons in materials science and the development of many nanoparticle-based extra- and intracellular biodiagnostic and the... [more]
Miska, Jason
Assistant Professor
Bio
The goal of Dr. Miska's research is to determine how the metabolism of immune cells within glioblastoma contributes to immune suppression and tumor recurrence. Furthermore, the long-term goal of ... [more]
Mohindra, Nisha
Associate Professor
Bio
Her research interests focus on the clinical investigation of novel agents or combination therapies for non-small cell and small cell lung cancer. She is also interested in developing quality of life ... [more]
Mulcahy, Mary F.
Professor
Bio
Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer
Patel, Jyoti D.
Professor
Bio
I am a medical oncologist with expertise in clinical and translational research in thoracic cancers and clinical drug development. I have led multiple clinical trials with novel drugs at all levels, f... [more]
Peter, Marcus
Professor
Bio
Dr. Peter has been working in the apoptosis and death receptor field for 19 years. His initial work in 1995 described the first multiprotein complex in apoptosis, the CD95 death-inducing signaling com... [more]
Platanias, Leonidas C.
Professor
Bio
Dr. Platanias' laboratory is focused on studying abnormalities in signal transduction pathways in malignant myeloid cells. The ultimate goal of the work in Dr. Platanias' laboratory is to identify int... [more]
Pollack, Seth
Associate Professor
Bio
The goal of my research is to cure patients with advanced sarcomas with immunotherapy. My research has mainly focused at targeting the immunogenic protein NY-ESO-1 which is highly expressed in certain... [more]
Roque, Dario
Associate Professor
Bio
Dr. Roque's research and clinical work focus on gynecologic cancers. He is interested in the development of clinical trials assessing the role of innovative therapies in the management of gynecol... [more]
Salem, Riad
Professor
Bio
My primary research interest is the induction of transplant tolerance; this applies to the prevention and treatment of a/cGVHD in hematopoietic stem cell transplantation and prevention and t... [more]